Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin

被引:0
|
作者
Gunn, Nadege T. [1 ]
Ling, Lei [2 ]
Neff, Guy [3 ]
Guy, Cynthia [4 ]
Bashir, Mustafa [4 ]
Paredes, Angelo [5 ]
Frias, Juan [6 ]
Younes, Ziad H. [7 ]
Trotter, James F. [8 ]
Moussa, Sam [9 ]
Kohli, Anita [10 ]
Connelly, Margery A. [11 ]
Nelson, Kristen [2 ]
Gottwald, Mildred [2 ]
Chang, William [2 ]
Yan, Andrew [2 ]
DePaoli, Alex [2 ]
Lieu, Hsiao [2 ]
Harrison, Stephen [12 ]
机构
[1] Pinnacle Clin Res, Austin, TX USA
[2] NGM Biopharmaceut, San Francisco, CA USA
[3] Covenant Res & Clin, Ft Myers, FL USA
[4] Duke Univ, Durham, NC 27706 USA
[5] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA
[6] Natl Res Inst, Los Angeles, CA USA
[7] Gastro One Res, Germantown, TN USA
[8] Texas Digest Dis Consultants, Dallas, TX USA
[9] Adobe Clin Res, Tucson, AZ USA
[10] Arizona Liver Hlth, Chandler, AZ USA
[11] Labcorp, Morrisville, NC USA
[12] Pinnacle Clin Res, San Antonio, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-1082
引用
收藏
页码:S617 / S617
页数:1
相关论文
共 50 条
  • [1] LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282)
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa
    Frias, Juan Pablo
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William
    Yan, Andrew Z.
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen A.
    HEPATOLOGY, 2020, 72 : 1022 - 1023
  • [2] FINAL ANALYSIS OF A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ALDAFERMIN (NGM282) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
    Harrison, Stephen A.
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa
    Paredes, Angelo
    Pablo Fries, Juan
    Younes, Ziad H.
    Trotter, James F.
    Gunn, Nadege T.
    Moussa, Sam
    Kohli, Anita
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William
    Yan, Andrew Z.
    DePaoli, Alex
    Ling, Lei
    Lieu, Hsiao
    HEPATOLOGY, 2020, 72 : 55A - 56A
  • [3] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bolliger, Chris T.
    Issa, Jaqueline S.
    Posadas-Valay, Rodolfo
    Safwat, Tarek
    Abreu, Paula
    Correia, Eurico A.
    Park, Peter W.
    Chopra, Pravin
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477
  • [4] Aldafermin reduces hydrophobic bile acids in a 24-week, randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis
    Sanyal, Arun
    Ling, Lei
    Neff, Guy
    Guy, Cynthia
    Bashir, Mustafa
    Paredes, Angelo
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Gunn, Nadege T.
    Moussa, Sam
    Kohli, Anita
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S616 - S617
  • [5] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Montgomery, SA
    Nil, R
    Dürr-Pal, N
    Loft, H
    Boulenger, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278
  • [6] Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study
    Magid, Michelle
    Reichenberg, Jason S.
    Poth, Poppy E.
    Robertson, Henry T.
    LaViolette, Amanda K.
    Kruger, Tillmann H. C.
    Wollmer, M. Axel
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (08) : 837 - +
  • [7] Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study
    Grube, Barbara
    Chong, Pee-Win
    Alt, Felix
    Uebelhack, Ralf
    JOURNAL OF OBESITY, 2015, 2015
  • [8] Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
    Alrutz Barcelos, Samantha Thifani
    Silva-Sperb, Amanda Souza
    Moraes, Helena Abadie
    Longo, Larisse
    de Moura, Bruna Concheski
    Michalczuk, Matheus Truccolo
    Uribe-Cruz, Carolina
    Schmidt Cerski, Carlos Thadeu
    da Silveira, Themis Reverbel
    Dall'Alba, Valesca
    Alvares-da-Silva, Mario Reis
    ANNALS OF HEPATOLOGY, 2023, 28 (01)
  • [9] Vitamin E does not reduce symptoms of rheumatoid arthritis: A 24-week randomized, double-blind, placebo-controlled study.
    Boileau, N
    Blumberg, J
    Dallal, GE
    Golly, I
    Roubenoff, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S179 - S179
  • [10] A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis
    Khanna, Dinesh
    Denton, Christopher P.
    Furst, Daniel E.
    Mayes, Maureen D.
    Matucci-Cerinic, Marco
    Smith, Vanessa
    de Vries, Dick
    Ford, Paul
    Bauer, Yasmina
    Randall, Matthew J.
    Ebrahimpoor, Mitra
    Kupcsik, Laszlo
    Stiers, Pieter-Jan
    Deberdt, Liesbeth
    Prasad, Niyati
    Lim, Sharlene
    Pujuguet, Philippe
    Ahmed, Sohail
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (08) : 1434 - 1444